Development of a Family-Based Treatment for Adolescent Methamphetamine Use
AIMS
1 other identifier
interventional
60
1 country
1
Brief Summary
The AIMS study compares a methamphetamine-specific treatment intervention to a treatment-as-usual Functional Family Therapy (FFT) approach for adolescents ages 15 to 19. Adolescents are assigned to one of two treatment conditions: (1) 16 weeks of FFT designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use; or (2) 16 weeks of a combination of FFT and a methamphetamine-specific intervention involving group and individual therapy sessions; Families are assessed using questionnaires and interviews, and adolescents participate in neuropsychological testing, before, during, and after treatment to provide information about family functioning, the adolescent's drug use, the adolescent's peers, and other factors that may contribute to treatment success. Adolescents also provide urine specimens for drug screening at assessment visits. Through a partnership with Oregon Health and Science University (OHSU), adolescents will participate in functional magnetic resonance imaging appointments at the hospital to examine regional brain blood flow during tasks designed to measure impulsivity and risk-taking behaviors. As a treatment development grant, study investigators will study adolescents' acceptance of and response to the newly developed methamphetamine-specific treatment approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Sep 2007
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 16, 2008
CompletedFirst Posted
Study publicly available on registry
May 20, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedAugust 5, 2014
August 1, 2014
6 years
May 16, 2008
August 4, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Substance Use
6 months
Secondary Outcomes (1)
Engagement and retention of adolescent methamphetamine users.
6 months
Study Arms (2)
1
ACTIVE COMPARATORFamily therapy combined with methamphetamine-specific group treatment.
2
ACTIVE COMPARATORFamily Therapy.
Interventions
AMT Group Therapy plus Functional Family Therapy (FFT)
Eligibility Criteria
You may qualify if:
- to 19 years of age.
- Have at least one parent or parent figure willing to participate.
- Meet DSM-IV diagnostic criteria for drug-abuse or dependence, including a specific meth use disorder.
- Reports meth use on at least 5 of the previous 90 days.
- Have contact with the parent on at least 40% of the past 90 days.
- With their parent be willing to accept randomization to one of the two treatment interventions.
- Be willing to participate in the imaging task in the fMRI pilot study.
- Have basic English competency.
- Have sufficient residential stability to permit probable contact at follow-up.
You may not qualify if:
- Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures.
- Have a medical or psychological condition that would preclude undergoing the fMRI scan.
- Have a sibling who is participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oregon Research Institutelead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Oregon Research Institute Center for Family and Adolescent Research
Portland, Oregon, 97205, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Holly B. Waldron, Ph.D.
Oregon Research Institute
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2008
First Posted
May 20, 2008
Study Start
September 1, 2007
Primary Completion
September 1, 2013
Study Completion
December 1, 2013
Last Updated
August 5, 2014
Record last verified: 2014-08